Novel synthesis and structural characterization of a high-affinity paramagnetic kinase probe for the identification of non-ATP site binders by nuclear magnetic resonance.

To aid in the pursuit of selective kinase inhibitors, we have developed a unique ATP site binder tool for the detection of binders outside the ATP site by nuclear magnetic resonance (NMR). We report here the novel synthesis that led to this paramagnetic spin-labeled pyrazolopyrimidine probe (1), which exhibits nanomolar inhibitory activity against multiple kinases. We demonstrate the application of this probe by performing NMR binding experiments with Lck and Src kinases and utilize it to detect the binding of two compounds proximal to the ATP site. The complex structure of the probe with Lck is also presented, revealing how the probe fits in the ATP site and the specific interactions it has with the protein. We believe that this spin-labeled probe is a valuable tool that holds broad applicability in a screen for non-ATP site binders.

[1]  L. Johnson,et al.  Protein Kinase Inhibitors: Insights into Drug Design from Structure , 2004, Science.

[2]  Randy J Read,et al.  Recent developments in the PHENIX software for automated crystallographic structure determination. , 2004, Journal of synchrotron radiation.

[3]  C. L. Habraken,et al.  Pyrazoles. 19. Selective thermolysis reactions of bromo-1-nitro-1H-pyrazoles. Formation of 3-nitro-1H- vs. 4-nitro-1H-pyrazoles , 1986 .

[4]  Wolfgang Jahnke,et al.  Second-Site NMR Screening with a Spin-Labeled First Ligand , 2000 .

[5]  T. Leipert,et al.  Rotating frame nuclear relaxation of PBr3: Off-resonance studies by fourier transform NMR , 1975 .

[6]  Wolfgang Jahnke,et al.  Second-site NMR screening and linker design. , 2003, Current topics in medicinal chemistry.

[7]  L. Tong,et al.  Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site , 2002, Nature Structural Biology.

[8]  K. L. Milkiewicz,et al.  The design, synthesis and activity of non-ATP competitive inhibitors of pp60(c-src) tyrosine kinase. Part 1: hydroxynaphthalene derivatives. , 2000, Bioorganic & medicinal chemistry letters.

[9]  R. K. Robins,et al.  Synthesis and enzymic activity of 6-carbethoxy- and 6-ethoxy-3,7-disubstituted-pyrazolo[1,5-a]pyrimidines and related derivatives as adenosine cyclic 3' ,5'-phosphate phosphodiesterase inhibitors. , 1982, Journal of medicinal chemistry.

[10]  Jeffrey W. Peng,et al.  Theory and Applications of NMR‐Based Screening in Pharmaceutical Research , 2004 .

[11]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[12]  W. Jahnke,et al.  Spin label enhanced NMR screening. , 2001, Journal of the American Chemical Society.

[13]  L. Johnson.  Protein kinase inhibitors: contributions from structure to clinical compounds , 2009, Quarterly Reviews of Biophysics.

[14]  G. Bemis,et al.  The properties of known drugs. 1. Molecular frameworks. , 1996, Journal of medicinal chemistry.

[15]  G. Bodenhausen,et al.  Principles of nuclear magnetic resonance in one and two dimensions , 1987 .

[16]  B. Druker.  Imatinib as a paradigm of targeted therapies , 2003 .

[17]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[18]  M. Pellecchia,et al.  Development of paramagnetic probes for molecular recognition studies in protein kinases. , 2008, Journal of medicinal chemistry.

[19]  D. Barford,et al.  Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF , 2004, Cell.

[20]  K. West,et al.  CP-690550, a JAK3 inhibitor as an immunosuppressant for the treatment of rheumatoid arthritis, transplant rejection, psoriasis and other immune-mediated disorders. , 2009, Current opinion in investigational drugs.

[21]  M. Deschamps,et al.  Probing protein-peptide binding surfaces using charged stable free radicals and transverse paramagnetic relaxation enhancement (PRE) , 2005, Journal of biomolecular NMR.

[22]  Geoffrey Bodenhausen,et al.  Gaussian pulse cascades: New analytical functions for rectangular selective inversion and in-phase excitation in NMR , 1990 .

[23]  Susan Adams,et al.  Structural Basis of Src Tyrosine Kinase Inhibition with a New Class of Potent and Selective Trisubstituted Purine‐based Compounds , 2006, Chemical biology & drug design.

[24]  S. Grant.  Therapeutic Protein Kinase Inhibitors , 2009, Cellular and Molecular Life Sciences.

[25]  Maurizio Pellecchia,et al.  Solution nuclear magnetic resonance spectroscopy techniques for probing intermolecular interactions. , 2005, Chemistry & biology.

[26]  M. McCoy,et al.  Screening of protein kinases by ATP-STD NMR spectroscopy. , 2005, Journal of the American Chemical Society.

[27]  M. H. Elnagdi,et al.  Recent Developments in Aminopyrazole Chemistry , 2009 .

[28]  Thomas Peters,et al.  NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. , 2003, Angewandte Chemie.

[29]  John Kuriyan,et al.  Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). , 2001, Cancer research.

[30]  O. Witte,et al.  The BCR-ABL story: bench to bedside and back. , 2004, Annual review of immunology.

[31]  Wolfgang Jahnke,et al.  Spin Labels as a Tool to Identify and Characterize Protein–Ligand Interactions by NMR Spectroscopy , 2002, Chembiochem : a European journal of chemical biology.

[32]  Bernd Meyer,et al.  Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy. , 1999, Angewandte Chemie.